As of the 19th of February, Cipher Pharmaceuticals shows the Risk Adjusted Performance of 0.0778, downside deviation of 1.5, and Mean Deviation of 1.39. Cipher Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cipher, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Cipher
Cipher
Cipher Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
It's important to distinguish between Cipher Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cipher Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cipher Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cipher Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cipher Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cipher Pharmaceuticals.
0.00
11/21/2025
No Change 0.00
0.0
In 3 months and 1 day
02/19/2026
0.00
If you would invest 0.00 in Cipher Pharmaceuticals on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Cipher Pharmaceuticals or generate 0.0% return on investment in Cipher Pharmaceuticals over 90 days. Cipher Pharmaceuticals is related to or competes with Canopy Growth, OrganiGram Holdings, TerrAscend Corp, Aurora Cannabis, Spectral Med, NervGen Pharma, and High Tide. Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada More
Cipher Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cipher Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cipher Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cipher Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cipher Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cipher Pharmaceuticals historical prices to predict the future Cipher Pharmaceuticals' volatility.
As of now, Cipher Stock is not too volatile. Cipher Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0478, which signifies that the company had a 0.0478 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Cipher Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Cipher Pharmaceuticals' Mean Deviation of 1.39, risk adjusted performance of 0.0778, and Downside Deviation of 1.5 to double-check if the risk estimate we provide is consistent with the expected return of 0.0814%. Cipher Pharmaceuticals has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cipher Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cipher Pharmaceuticals is expected to be smaller as well. Cipher Pharmaceuticals right now shows a risk of 1.7%. Please confirm Cipher Pharmaceuticals total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Cipher Pharmaceuticals will be following its price patterns.
Auto-correlation
0.13
Insignificant predictability
Cipher Pharmaceuticals has insignificant predictability. Overlapping area represents the amount of predictability between Cipher Pharmaceuticals time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cipher Pharmaceuticals price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Cipher Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.13
Spearman Rank Test
-0.25
Residual Average
0.0
Price Variance
0.15
Cipher Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cipher Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cipher Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Cipher Pharmaceuticals Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cipher Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Cipher Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cipher Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cipher Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Cipher Pharmaceuticals. By analyzing Cipher Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cipher Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cipher Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Cipher Pharmaceuticals February 19, 2026 Technical Indicators
Most technical analysis of Cipher help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cipher from various momentum indicators to cycle indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cipher Pharmaceuticals February 19, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Cipher stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.